image

FDA WARNS CURALEAF ON CBD CLAIMS

The U.S. Food and Drug Administration sent a warning letter to MSO Curaleaf about making unproven claims that CBD can treat diseases such as Alzheimer’s.
MarketWatch

  • It was the first such letter the agency has sent to a multi-state operator. The company said it intends to remain compliant.
  • “Among MSOs, Curaleaf has made the largest push into CBD – with a full “Curaleaf Hemp” line,” a Wall Street analyst said. “And the CVS partnership brought them a lot of attention…They’re a good company to make an example of “
  • Curaleaf, the most valuable U.S. cannabis company, saw its stock drop on the news.
    Business Insider

Quick Hit

  1. In Canada, CannTrust CEO Peter Aceto resigned in the wake of news the company had been growing in unlicensed rooms. ????Jesse has all the details at WW Canada!
    MarketWatc
    h